Laryngeal cancer is a type of cancer where malignant cells are found in the larynx tissue and usually present with ear pain and sore throat. The condition can have a negative impact on patients if not timeously diagnosed and an appropriate treatment administered. The implication is that health professionals need to understand the appropriate treatment to be used. Fortunately, various treatment options exist which can be used. However, it is important to note that the treatment approach to be employed considerably depends on the size of cancer. In addition, in employing treatment approaches, a common practice is the use of multidisciplinary teams with various specialists who consider a patient case by case and then work together the choose the best treatment approaches (Baird et al., 2018). The major approaches include targeted cancer medicines, chemotherapy, surgery, and radiotherapy
Radiotherapy as a laryngeal cancer treatment approach involves the use of controlled doses of high-energy radiation to help destroy the cancerous cell. In most cases, this approach is employed to treat the condition when it is in the early stages and can also be used to help stop the return of cancerous cells (Obid et al., 2019). The approach can also be used in combination with chemotherapy. The condition can also be treated through surgery where approaches such as total laryngectomy, partial laryngectomy, and endoscopic resection. The endoscopic resection approach is usually used in early-stage laryngeal cancer; the partial laryngectomy approach involves surgical removal of the affected part of the larynx, while total laryngectomy is used in treating advanced laryngeal cancer and involves the removal of the entire larynx. The next aspect is the use of chemotherapy which involves the use of cancer-killing medications to help damage the cancerous cells’ DNA in a bid to stop them from reproducing.
References
Baird, B. J., Sung, C. K., Beadle, B. M., & Divi, V. (2018). Treatment of early-stage laryngeal cancer: a comparison of treatment options. Oral Oncology, 87, 8-16. https://doi.org/10.1016/j.oraloncology.2018.09.012
Order this paper